Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.


Updates from The Motley Fool

Latest updates on Novartis from Fool.com.  The Fool has written over 500 articles on Novartis.
Novartis Takes Aim at Pfizer

Novartis ' (NYSE: NVS) application for FDA approval of ribociclib for first-line use alongside le...

3 Reasons To Buy Biogen

Image source: Getty Images. Biotechnology stocks are regaining a bit of their luster lately; but ...

3 Growth Stocks to Buy in June

If you're going to pay a hefty premium for a stock, it better have exceptional growth prospects. ...

Momenta Blocked

Momenta Pharmaceuticals (NASDAQ: MNTA) released fourth-quarter earnings on Thursday with all eye...



Stock Performance

View Interactive NVS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Novartis.
Current Price: $68.92
Prev Close: $68.97
Open: $68.86
Bid: $68.92
Ask: $68.93
Day's Range: $68.55 - $69.08
52wk Range: $67.28 - $88.49
Volume: 1,431,080
Avg Vol 3,561,796
Market Cap: $165B
P/E (ttm): 18.64
EPS (ttm): $0.00
Div & Yield: $2.67 (3.3%)

Company Rating

What our community thinks about Novartis.
CAPS Rating 4 out of 5
 
1457 Outperform
44 Underperform
CAPS All Stars
 
349 Outperform
11 Underperform

How do you think Novartis will perform against the market?



You pick for Novartis is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Joseph Jimenez, CEO

88% Approve

Based on 74 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Novartis.

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers